ArticlebioRxiv : the preprint server for biology2021
Combination of Antiviral Drugs to Inhibit SARS-CoV-2 Polymerase and Exonuclease as Potential COVID-19 Therapeutics.
Xuanting Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.